BICO News Feed​

Discover the latest news from our business areas.
  • 8:28 am

The US senate has passed the FDA Modernization Act

Share on facebook
Share on twitter
Share on linkedin

The US Senate has passed the FDA Modernization Act with unanimous consent!

A massive stride in the acceptance of alternatives to animal models in drug discovery. Alternatives that capture human physiology better, that are more ethical, sustainable and most importantly, alternatives that can accelerate the discovery of life changing therapies. Alternatives that our bioprinters have proudly supported and enabled since our inception. Alternatives that we are committed to continuing to develop and democratize.
Learn more

More news

March 19, 2024 | Scienion

sciFLEXARRAYER User Training in Berlin
December 4, 2023 | Cellink

Stefan Blomsterberg appointed as new CEO of CELLINK Bioprinting AB 
November 30, 2023 | Cellink

CELLINK and Ossiform Enter a Strategic Partnership to launch Ossi Ink, a printable bioink based on Ossiform’s P3D Bone material
November 21, 2023 | Cellenion

Cellenion Launches proteoCHIP EVO 96 – Tailored for robust and high-throughput liquid chromatography
November 16, 2023 | Scienion

MEDICA 2023: reliable, versatile, and trusted solutions for innovative diagnostics
October 18, 2023 | Cellink

CELLINK Announces CELLINK Vivoink: Our First Medical-Grade Bioink 
July 10, 2023 | Scienion

SCIENION UK: a global hub for IVD contract manufacturing services
June 2, 2023 | Bico

MatTek and AIM Biotech Partner on Advanced 3D Tissue Culture Organ-on-a-Chip Systems
May 10, 2023 | Bico

Biosero, a BICO company partners with Hamilton for Automated Liquid Handling Workflows
Load more